. Author manuscript; available in PMC: 2022 Feb 23.

Published in final edited form as: IEEE Access. 2021 Dec 6;9:163526–163541. doi: 10.1109/ACCESS.2021.3132958

TABLE 3.

Comparison of ScATNet with pathologists’ (PG) performance. Pathologists’ performance data is from a prior independent clinical study of 187 pathologists [6] who interpreted these same 115 cases in our test set (Table 1). Diagnostic terms are defined as the following: mild and moderate dysplastic nevi (MMD), melanoma in situ (MIS), invasive melanoma stage pT1a (pT1a), invasive melanoma stage ≥pT1b (pT1b).

Diagnostic Category	Accuracy		F1		Sensitivity		Specificity
Diagnostic Category	PG	Ours	PG	Oars	PG	Ours	PG	Ours
MMD	0.92	0.79	0.71	0.75	0.92	0.79	0.76	0.89
MIS	0.46	0.40	0.49	0.44	0.46	0.40	0.85	0.84
pT1a	0.51	0.65	0.62	0.63	0.51	0.65	0.95	0.84
pT1b	0.72	0.77	0.72	0.74	0.78	0.77	0.97	0.92

Overall	0.65	0.64	0.65	0.64	0.65	0.64	0.88	0.88